WHO ICTRP trial
A placebo controlled, single-blind, single oral dose study to determine the…
ISRCTN91111837 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN91111837 |
|---|---|
| Public title | A placebo controlled, single-blind, single oral dose study to determine the safety and immunogenicity of M01ZH09 typhoid vaccine (oral live S. typhi [Ty2 aroC- ssaV-] ZH9) in healthy paediatric subjects, aged five to 14 years inclusive, of Vietnamese origin |
| Primary sponsor | Emergent Product Development UK Ltd (UK) |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | Viet Nam |
| Conditions | Typhoid fever prophylaxis Infections and Infestations Typhoid fever |
| Interventions | Subjects deemed eligible after screening will be randomised to receive an oral dose of either active vaccine or matching placebo. Safety will be monitored by: 1. Diary recordings of body temperature 2. Assessment of Adverse Events (AEs) 3… |
| Registration date | Jul 2, 2007 |
| Target size | 150 |
| Secondary IDs | 075596 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: